Matches in Wikidata for { <http://www.wikidata.org/entity/Q92056747> ?p ?o ?g. }
- Q92056747 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q92056747 description "im Juli 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92056747 description "scientific article published on 18 July 2019" @default.
- Q92056747 description "wetenschappelijk artikel" @default.
- Q92056747 description "наукова стаття, опублікована 18 липня 2019" @default.
- Q92056747 description "գիտական հոդված հրատարակված 2019 թվականի հուլիսի 18-ին" @default.
- Q92056747 name "Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial" @default.
- Q92056747 name "Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial" @default.
- Q92056747 type Item @default.
- Q92056747 label "Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial" @default.
- Q92056747 label "Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial" @default.
- Q92056747 prefLabel "Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial" @default.
- Q92056747 prefLabel "Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial" @default.
- Q92056747 P1433 Q92056747-8DE37F77-4099-45AA-91E0-59DEF58A1638 @default.
- Q92056747 P1476 Q92056747-AEB6C03F-A3A3-439D-A139-5D681EF5B2FF @default.
- Q92056747 P2093 Q92056747-035999F7-3C6B-4FFA-AE81-BB53C358BE58 @default.
- Q92056747 P2093 Q92056747-16545718-7F88-45EA-889F-9F7F9D119FAA @default.
- Q92056747 P2093 Q92056747-1EC9E954-5A29-4FBB-9207-39A3B3BC8E58 @default.
- Q92056747 P2093 Q92056747-20ACC417-E156-4AD3-A27F-FE25DD31C5CB @default.
- Q92056747 P2093 Q92056747-215F18E5-FE0D-4F8F-B883-4C9BC6529C96 @default.
- Q92056747 P2093 Q92056747-2EF7CA51-6E43-4853-BAB6-18DCF4CBD2FD @default.
- Q92056747 P2093 Q92056747-35F28DA2-E023-4227-B0F7-AFC16A1F5652 @default.
- Q92056747 P2093 Q92056747-39BB7D18-9D70-4910-A286-3D4C33300730 @default.
- Q92056747 P2093 Q92056747-3FC38E3C-16F9-4693-88D5-0F672019DD6F @default.
- Q92056747 P2093 Q92056747-481D59A2-4C7E-4DE0-9100-776C0FCA333C @default.
- Q92056747 P2093 Q92056747-5135E2C4-6022-42F6-A5F4-E4A8A84652F1 @default.
- Q92056747 P2093 Q92056747-83C1F8AC-F56B-40FD-A0CA-BE25F6DB938F @default.
- Q92056747 P2093 Q92056747-842CB56F-2924-44F4-9E47-712E1A7F3BEF @default.
- Q92056747 P2093 Q92056747-91ACE6AF-3182-406D-95A8-3D3692A05BC7 @default.
- Q92056747 P2093 Q92056747-AE6B6B69-B0F7-44AD-88E9-FEFB4B680DE0 @default.
- Q92056747 P2093 Q92056747-B2D1F0AD-CCC7-4A0E-907F-4C9B8FFBCDD7 @default.
- Q92056747 P2093 Q92056747-B7512AA8-647E-4E5B-8164-25C7386EAA4D @default.
- Q92056747 P2093 Q92056747-BD029410-41AE-43C5-A980-4D7D6DE768FC @default.
- Q92056747 P2093 Q92056747-CF269235-8E89-4AFC-AA62-441C877C3027 @default.
- Q92056747 P2093 Q92056747-D4894370-EC11-4294-80F1-0C2730ABE0C5 @default.
- Q92056747 P2093 Q92056747-E556AB92-A96B-40CB-A955-E127A6E4AA65 @default.
- Q92056747 P2093 Q92056747-E56BB124-492F-42B4-855A-A6AEE1284EF5 @default.
- Q92056747 P2093 Q92056747-E9F8D032-8417-493E-AA21-0045BD7002D0 @default.
- Q92056747 P2093 Q92056747-EFC80537-5E53-407B-9A51-BCFA885C96CB @default.
- Q92056747 P2093 Q92056747-F5AC9461-34E4-457A-A925-7D61C0A7269A @default.
- Q92056747 P2860 Q92056747-0F4271F4-543D-402D-ADA8-59A24043191D @default.
- Q92056747 P2860 Q92056747-10CDE316-40D4-41B0-B2DA-DDF06D2C367B @default.
- Q92056747 P2860 Q92056747-1ACD8275-43AB-4144-A096-FC15A355F20F @default.
- Q92056747 P2860 Q92056747-22C92E7C-D526-494D-AACE-FE1443383883 @default.
- Q92056747 P2860 Q92056747-2C17F9D1-D6BB-4612-8FC2-7B4541CC859A @default.
- Q92056747 P2860 Q92056747-35F2A9D1-7534-4706-8A24-AF58A29D38F8 @default.
- Q92056747 P2860 Q92056747-4FE1AF13-70B4-4187-800E-4D3B3DB60D5F @default.
- Q92056747 P2860 Q92056747-56F4A756-F546-481B-AC6D-96B0CE81695D @default.
- Q92056747 P2860 Q92056747-5F70915D-31EF-4101-B63C-A5CE57806EF9 @default.
- Q92056747 P2860 Q92056747-6565B276-BF67-4578-A2C8-476868BB6830 @default.
- Q92056747 P2860 Q92056747-67BC3470-0BB3-4B86-9E63-19ABA13E8E34 @default.
- Q92056747 P2860 Q92056747-78820D74-27AF-4F11-91AC-C796CB774270 @default.
- Q92056747 P2860 Q92056747-87DD6256-887E-464D-B099-66C614ABC88C @default.
- Q92056747 P2860 Q92056747-89BB53D5-F057-4B23-8A20-E19697BE31D9 @default.
- Q92056747 P2860 Q92056747-8A0F6951-5F0C-4AAE-9219-F7BE6D141B17 @default.
- Q92056747 P2860 Q92056747-8D7B2CE9-D1A1-4B92-956F-EF3E2DDC42D0 @default.
- Q92056747 P2860 Q92056747-A0F3838D-5F8D-4F4E-A469-A05E63DE433E @default.
- Q92056747 P2860 Q92056747-A6E16478-0D12-440B-B412-A38B226EAF9D @default.
- Q92056747 P2860 Q92056747-B1B02037-375B-4429-BECE-8D0EDBF7FDF0 @default.
- Q92056747 P2860 Q92056747-BADC22A0-5AB1-4FFD-AD37-498C59B43F18 @default.
- Q92056747 P2860 Q92056747-C128B9CC-E5D6-43C7-92BE-F70CC10E7C35 @default.
- Q92056747 P2860 Q92056747-D5309104-7393-4EBF-8492-B21F051E4321 @default.
- Q92056747 P2860 Q92056747-DD85C0DF-F302-455C-8B39-ACAACC3E97CA @default.
- Q92056747 P2860 Q92056747-E47ED21A-BFCB-4150-83FA-5E42320AFA5B @default.
- Q92056747 P304 Q92056747-8767171A-CDEB-420F-83E6-AA1CCA26E794 @default.
- Q92056747 P31 Q92056747-6A13A850-F650-4146-86EA-EBA3CDB46F43 @default.
- Q92056747 P356 Q92056747-CE77837F-0525-4D7A-A45A-D81520E841D4 @default.
- Q92056747 P433 Q92056747-41A4C802-68A0-4E86-804E-8B228555C699 @default.
- Q92056747 P478 Q92056747-43190FBA-D255-4DB3-B5E0-B5819542E078 @default.
- Q92056747 P50 Q92056747-D2FD199E-8826-4DB3-820C-BEA7288EF1FE @default.
- Q92056747 P50 Q92056747-E8A0FAAE-CF2C-4A89-82BB-86FE665179A5 @default.
- Q92056747 P577 Q92056747-D11FD218-DD9C-4C93-AC16-74FA5B08A287 @default.
- Q92056747 P698 Q92056747-3478E52A-DBAF-49C7-B80E-179F10BAB62F @default.
- Q92056747 P921 Q92056747-73174431-AE17-49AB-830D-F388E6F535F7 @default.
- Q92056747 P921 Q92056747-C3EE3A01-8268-42A6-AB95-6045A0A81C85 @default.
- Q92056747 P921 Q92056747-F528524D-89F4-42CE-A46C-31B3BA294216 @default.
- Q92056747 P356 S2352-3026(19)30110-3 @default.
- Q92056747 P698 31327687 @default.
- Q92056747 P1433 Q26840042 @default.
- Q92056747 P1476 "Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial" @default.
- Q92056747 P2093 "Albert Oriol" @default.
- Q92056747 P2093 "Alessandra Larocca" @default.
- Q92056747 P2093 "Anupkumar George" @default.
- Q92056747 P2093 "Asher Chanan-Khan" @default.
- Q92056747 P2093 "Daniel Sherbenou" @default.
- Q92056747 P2093 "David Simpson" @default.
- Q92056747 P2093 "Enrique M Ocio" @default.
- Q92056747 P2093 "Fredrik Schjesvold" @default.
- Q92056747 P2093 "Hilary Blacklock" @default.
- Q92056747 P2093 "Jason Liao" @default.
- Q92056747 P2093 "Jesus San Miguel" @default.
- Q92056747 P2093 "KEYNOTE-183 Investigators" @default.
- Q92056747 P2093 "Kenshi Suzuki" @default.
- Q92056747 P2093 "Maria-Victoria Mateos" @default.
- Q92056747 P2093 "Mohammed Farooqui" @default.
- Q92056747 P2093 "Morio Matsumoto" @default.
- Q92056747 P2093 "Noam Benyamini" @default.
- Q92056747 P2093 "Patricia Marinello" @default.
- Q92056747 P2093 "Paula Rodriguez-Otero" @default.
- Q92056747 P2093 "Saad Z Usmani" @default.